Private Wealth Asset Management LLC purchased a new stake in shares of Ibotta, Inc. (NYSE:IBTA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 1,000 shares of the company’s stock, valued at approximately $37,000.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in Ibotta during the 1st quarter worth about $25,000. CWM LLC lifted its position in shares of Ibotta by 225.2% in the 2nd quarter. CWM LLC now owns 943 shares of the company’s stock worth $35,000 after purchasing an additional 653 shares during the period. GAMMA Investing LLC lifted its position in shares of Ibotta by 2,859.7% in the 1st quarter. GAMMA Investing LLC now owns 1,983 shares of the company’s stock worth $840,000 after purchasing an additional 1,916 shares during the period. Jones Financial Companies Lllp bought a new position in shares of Ibotta during the first quarter valued at approximately $161,000. Finally, New York State Common Retirement Fund raised its stake in Ibotta by 58.1% in the first quarter. New York State Common Retirement Fund now owns 4,900 shares of the company’s stock worth $207,000 after buying an additional 1,800 shares in the last quarter.
Ibotta Stock Down 0.3%
IBTA stock opened at $31.04 on Thursday. The stock has a market capitalization of $784.07 million, a PE ratio of 10.78, a price-to-earnings-growth ratio of 24.90 and a beta of -1.19. Ibotta, Inc. has a 52 week low of $22.50 and a 52 week high of $79.80. The firm has a 50 day moving average of $28.02 and a 200 day moving average of $38.38.
Analyst Upgrades and Downgrades
Several analysts have issued reports on the company. UBS Group dropped their target price on Ibotta from $55.00 to $30.00 and set a “neutral” rating on the stock in a research report on Thursday, August 14th. Evercore ISI reiterated an “in-line” rating and issued a $38.00 target price (down previously from $65.00) on shares of Ibotta in a research note on Thursday, August 14th. JMP Securities reissued a “market perform” rating on shares of Ibotta in a research report on Thursday, August 14th. Citigroup downgraded shares of Ibotta from a “buy” rating to a “market perform” rating in a research report on Thursday, August 14th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Ibotta in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $34.14.
Read Our Latest Stock Report on Ibotta
About Ibotta
Ibotta’s mission is to Make Every Purchase Rewarding. Our technology allows CPG brands to deliver digital promotions to over 200 million consumers through a single, convenient network called the Ibotta Performance Network (IPN). We are pioneers in success-based marketing: we only get paid when our client’s promotion results in a sale, not when a consumer merely views or clicks on the promotion.
Recommended Stories
- Five stocks we like better than Ibotta
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- CD Calculator: Certificate of Deposit Calculator
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding IBTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ibotta, Inc. (NYSE:IBTA – Free Report).
Receive News & Ratings for Ibotta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ibotta and related companies with MarketBeat.com's FREE daily email newsletter.
